Experience

Essange Reagents

• Netherlands
• Hospitals and Health Care
• 1 - 100 Employee

• Analist

  • Dec 2022 - Present



Sanquin

• Netherlands
• Hospitals and Health Care
• 700 & Above Employee

• Analist POR

  • Jun 2019 - Nov 2022



UbiQ

• Netherlands
• Biotechnology
• 1 - 100 Employee

• Afstudeerstage

  • Oct 2017 - May 2018

  Optimising protocols, for testing inhibitors of the SUMO pathway on lysate. Setting up a SDS PAGE protocol from scratch. Testing a flourescent cell permeable probe on cancer cells, with fluorescent imaging, and cell lysing ussing an activity-based protein profiling assay. Optimising protocols, for testing inhibitors of the SUMO pathway on lysate. Setting up a SDS PAGE protocol from scratch. Testing a flourescent cell permeable probe on cancer cells, with fluorescent imaging, and cell lysing ussing an activity-based protein profiling assay.



University of Amsterdam

• Netherlands
• Research Services
• 700 & Above Employee

• Stagestudent

  • Oct 2016 - Feb 2017

  Studying the impact of the interaction between the cyclin-dependent kinase inhibitor (Sic1) and the transcriptionfactor (Fkh2), on the timing of the cell cycle progression of S. cerevisiae. Studying the impact of the interaction between the cyclin-dependent kinase inhibitor (Sic1) and the transcriptionfactor (Fkh2), on the timing of the cell cycle progression of S. cerevisiae.